AI assistant
CONMED Corp — Director's Dealing 2014
Jul 31, 2014
31971_dirs_2014-07-31_3d4f5fb6-b2e3-41ea-ad03-bf7543c38169.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-07-30
Reporting Person: CORASANTI JOSEPH J (Former President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-30 | Common Stock | M | 5000 | — | Acquired | 137685 | Direct |
| 2014-07-30 | Common Stock | F | 2534 | $39.38 | Disposed | 135151 | Direct |
| 2014-07-30 | Common Stock | M | 10000 | — | Acquired | 145151 | Direct |
| 2014-07-30 | Common Stock | F | 5067 | $39.38 | Disposed | 140084 | Direct |
| 2014-07-30 | Common Stock | M | 15000 | — | Acquired | 155084 | Direct |
| 2014-07-30 | Common Stock | F | 7601 | $39.38 | Disposed | 147483 | Direct |
| 2014-07-30 | Common Stock | M | 20000 | — | Acquired | 167483 | Direct |
| 2014-07-30 | Common Stock | F | 10134 | $39.38 | Disposed | 157349 | Direct |
| 2014-07-30 | Common Stock | M | 16250 | — | Acquired | 173599 | Direct |
| 2014-07-30 | Common Stock | F | 8234 | $39.38 | Disposed | 165365 | Direct |
| 2014-07-30 | Common Stock | M | 62500 | $19.93 | Acquired | 227865 | Direct |
| 2014-07-30 | Common Stock | F | 47273 | $39.38 | Disposed | 180592 | Direct |
| 2014-07-30 | Common Stock | M | 62500 | $29.92 | Acquired | 243092 | Direct |
| 2014-07-30 | Common Stock | F | 55095 | $39.38 | Disposed | 187997 | Direct |
| 2014-07-30 | Common Stock | M | 62500 | $26.69 | Acquired | 250497 | Direct |
| 2014-07-30 | Common Stock | F | 52566 | $39.38 | Disposed | 197931 | Direct |
| 2014-07-30 | Common Stock | M | 62500 | $16.46 | Acquired | 260431 | Direct |
| 2014-07-30 | Common Stock | F | 44556 | $39.38 | Disposed | 215875 | Direct |
| 2014-07-30 | Common Stock | M | 40000 | $21.19 | Acquired | 255875 | Direct |
| 2014-07-30 | Common Stock | F | 30886 | $39.38 | Disposed | 224989 | Direct |
| 2014-07-30 | Common Stock | M | 62500 | $19.26 | Acquired | 287489 | Direct |
| 2014-07-30 | Common Stock | F | 46749 | $39.38 | Disposed | 240740 | Direct |
| 2014-07-30 | Common Stock | M | 62500 | $27.63 | Acquired | 303240 | Direct |
| 2014-07-30 | Common Stock | F | 53302 | $39.38 | Disposed | 249938 | Direct |
| 2014-07-30 | Common Stock | M | 62500 | $26.09 | Acquired | 312438 | Direct |
| 2014-07-30 | Common Stock | F | 52096 | $39.38 | Disposed | 260342 | Direct |
| 2014-07-30 | Common Stock | M | 62500 | $32.93 | Acquired | 322842 | Direct |
| 2014-07-30 | Common Stock | F | 57451 | $39.38 | Disposed | 265391 | Direct |
| 2014-07-30 | Common Stock | S | 109035 | $39.2483 | Disposed | 156356 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-30 | Rsus (restricted Stock Units) | $0 | M | 5000 | Disposed | 2020-06-01 | Common Stock (5000) | Direct |
| 2014-07-30 | Rsus (restricted Stock Units) | $0 | M | 10000 | Disposed | 2021-06-01 | Common Stock (10000) | Direct |
| 2014-07-30 | Rsus (restricted Stock Units) | $0 | M | 15000 | Disposed | 2022-06-01 | Common Stock (15000) | Direct |
| 2014-07-30 | Rsus (restricted Stock Units) | $0 | M | 20000 | Disposed | 2023-06-01 | Common Stock (20000) | Direct |
| 2014-07-30 | Rsus (restricted Stock Units) | $0 | M | 16250 | Disposed | 2024-06-01 | Common Stock (16250) | Direct |
| 2014-07-30 | Sars (Stock Appreciation Rights) | $19.93 | M | 62500 | Disposed | 2016-05-16 | Common Stock (62500) | Direct |
| 2014-07-30 | Sars (Stock Appreciation Rights) | $29.92 | M | 62500 | Disposed | 2017-05-17 | Common Stock (62500) | Direct |
| 2014-07-30 | Sars (Stock Appreciation Rights) | $26.69 | M | 62500 | Disposed | 2018-06-01 | Common Stock (62500) | Direct |
| 2014-07-30 | Sars (Stock Appreciation Rights) | $16.46 | M | 62500 | Disposed | 2019-06-01 | Common Stock (62500) | Direct |
| 2014-07-30 | Sars (Stock Appreciation Rights) | $21.19 | M | 40000 | Disposed | 2019-10-30 | Common Stock (40000) | Direct |
| 2014-07-30 | Sars (Stock Appreciation Rights) | $19.26 | M | 62500 | Disposed | 2020-06-01 | Common Stock (62500) | Direct |
| 2014-07-30 | Sars (Stock Appreciation Rights) | $27.63 | M | 62500 | Disposed | 2021-06-01 | Common Stock (62500) | Direct |
| 2014-07-30 | Sars (Stock Appreciation Rights) | $26.09 | M | 62500 | Disposed | 2022-06-01 | Common Stock (62500) | Direct |
| 2014-07-30 | Sars (Stock Appreciation Rights) | $32.93 | M | 62500 | Disposed | 2023-06-01 | Common Stock (62500) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.35. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F3: According to Section 2(d) of the Separation and Release Agreement dated July 22, 2014, and attached as Exhibit 10.1 of the Form 8-K dated July 23, 2014, all of Mr. Joseph Corasanti's unvested RSUs and SARs accelerated, other than the 2014 SARS which were cancelled.
F4: The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.
F5: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.
F6: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F7: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a period with the first 20% tranche to vest on June 1, 2010 with each successive 20% tranche to vest on June 1 the following year.